Facebook
X
LinkedIn
ForwardFSR Clinical Education and Engagement Series: Advanced Cardiac Sarcoidosis
March 25, 2026
The Clinician Education and Engagement Series on Advanced Cardiac Sarcoidosis is a comprehensive long-form program developed to equip clinicians with practical insights and multidisciplinary strategies for managing complex cardiac sarcoidosis. Through a dynamic, case-based format, this session will explore critical aspects of cardiac involvement in sarcoidosis, emphasizing timely recognition, effective diagnostic evaluation, and individualized management approaches. Participants will examine the most impactful clinical decision points through presentations delivered by expert sarcoidosis cardiologists on the following topics:
- Advanced Cardiac Imaging: optimal use of cardiac MRI, PET, and other imaging modalities to confirm suspected cardiac sarcoidosis and to inform treatment strategies
- Cardiac Electrophysiology (EP) Treatment Options for Advanced Arrhythmic Manifestations: management of arrhythmic manifestations, device therapies, and interventional options for advanced cardiac sarcoidosis
- Heart Failure & Heart Transplant: treatment optimization, referral thresholds for advanced therapies (LVAD, transplant, etc.), and best practices for multidisciplinary coordination.
The session will also incorporate the pulmonary perspective through a discussion-based session between a cardiologist and pulmonologist regarding timing for cardiac screening, identifying appropriate thresholds for referral, and recognizing clinical indicators for advanced cardiac evaluation. The program concludes with a moderated panel that incorporates discussion of a patient case that integrates the session topics to increase understanding of evidence-based approaches to managing advanced cardiac sarcoidosis.
Target Audience
The intended audience includes general practitioners, cardiologists, pulmonologists, rheumatologists, and all specialties working with sarcoidosis.
Learning Objectives
At the conclusion of the program, clinicians should be able to:
- Recognize clinical indicators and appropriate timing for cardiac screening and referral in sarcoidosis patients and integrate multidisciplinary perspectives to improve patient outcomes;
- Apply best practices in the selection and interpretation of imaging modalities for diagnosing and assessing disease activity in cardiac sarcoidosis;
- Evaluate current cardiac electrophysiology approaches for managing arrhythmias and guiding device therapy in advanced cases;
- Discuss strategies for optimizing heart failure management and determining the need for advanced therapies such as LVAD or transplantation.
Online Webinar
United States
WANT TO KNOW MORE?
For questions about the program, contact Julie Collins via e-mail.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at [email protected].
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
COURSE FACULTY
Dr. Farooq Sheikh
MedStar
Dr. Paco Bravo
University of Pennsylvania
Dr. Kengo Kusano
National Cerebral and Cardiovascular Centre
Suita, Japan
Dr. Ravi Karra
Duke University
Dr. Justin Hewlett
Vanderbilt
Dr. Ashley Hardin
UT-Southwestern
MedStar
Dr. Paco Bravo
University of Pennsylvania
Dr. Kengo Kusano
National Cerebral and Cardiovascular Centre
Suita, Japan
Dr. Ravi Karra
Duke University
Dr. Justin Hewlett
Vanderbilt
Dr. Ashley Hardin
UT-Southwestern
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and The Foundation for Sarcoidosis Research. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School Of Medicine designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Participant Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please note: The credit claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Claiming Credit: Enter the access code to unlock the credit claiming process.
Please note: The credit claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Please note: The credit claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Please login or create an account to proceed.